Park et al. demonstrate in vivo the efficacy of Cas9 nanocomplexes as therapeutic agents in mouse models of Alzheimer’s disease. This strategy may be applicable to the treatment of a broad range of neurological diseases.
- Hanseul Park
- Jungju Oh
- Jongpil Kim